890 related articles for article (PubMed ID: 33776917)
1. The Centrality of Obesity in the Course of Severe COVID-19.
Liu D; Zhang T; Wang Y; Xia L
Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
[TBL] [Abstract][Full Text] [Related]
2. Diabetes, obesity and COVID-19: A complex interplay.
Vas P; Hopkins D; Feher M; Rubino F; B Whyte M
Diabetes Obes Metab; 2020 Oct; 22(10):1892-1896. PubMed ID: 32627299
[TBL] [Abstract][Full Text] [Related]
3. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19).
Zhou Y; Chi J; Lv W; Wang Y
Diabetes Metab Res Rev; 2021 Feb; 37(2):e3377. PubMed ID: 32588943
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.
Landstra CP; de Koning EJP
Front Endocrinol (Lausanne); 2021; 12():649525. PubMed ID: 34220706
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
Yin T; Li Y; Ying Y; Luo Z
BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
[TBL] [Abstract][Full Text] [Related]
8. Impact of obesity on COVID-19 patients.
Yu W; Rohli KE; Yang S; Jia P
J Diabetes Complications; 2021 Mar; 35(3):107817. PubMed ID: 33358523
[TBL] [Abstract][Full Text] [Related]
9. Diabetes and covid-19: more than the sum of two morbidities.
Pititto BA; Ferreira SRG
Rev Saude Publica; 2020; 54():54. PubMed ID: 32491053
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for Covid-19 severity and fatality: a structured literature review.
Wolff D; Nee S; Hickey NS; Marschollek M
Infection; 2021 Feb; 49(1):15-28. PubMed ID: 32860214
[TBL] [Abstract][Full Text] [Related]
11. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
[TBL] [Abstract][Full Text] [Related]
12. Sympathetic activation: a potential link between comorbidities and COVID-19.
Porzionato A; Emmi A; Barbon S; Boscolo-Berto R; Stecco C; Stocco E; Macchi V; De Caro R
FEBS J; 2020 Sep; 287(17):3681-3688. PubMed ID: 32779891
[TBL] [Abstract][Full Text] [Related]
13. Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19.
Khwatenge CN; Pate M; Miller LC; Sang Y
Front Immunol; 2021; 12():732913. PubMed ID: 34737743
[TBL] [Abstract][Full Text] [Related]
14. Health Conditions Associated With Severe Illness From COVID-19 Among Individuals With Serious Mental Illness.
Novak P; Sanmartin MX; Ali MM; Chen J
Psychiatr Serv; 2021 Apr; 72(4):468-469. PubMed ID: 33208029
[No Abstract] [Full Text] [Related]
15. Impact of Diabetes in Patients Diagnosed With COVID-19.
Abu-Farha M; Al-Mulla F; Thanaraj TA; Kavalakatt S; Ali H; Abdul Ghani M; Abubaker J
Front Immunol; 2020; 11():576818. PubMed ID: 33335527
[TBL] [Abstract][Full Text] [Related]
16. The Clinical Characteristics and Risk Factors of Severe COVID-19.
Hu J; Wang Y
Gerontology; 2021; 67(3):255-266. PubMed ID: 33406518
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
Bajgain KT; Badal S; Bajgain BB; Santana MJ
Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
[TBL] [Abstract][Full Text] [Related]
19. The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review.
James PT; Ali Z; Armitage AE; Bonell A; Cerami C; Drakesmith H; Jobe M; Jones KS; Liew Z; Moore SE; Morales-Berstein F; Nabwera HM; Nadjm B; Pasricha SR; Scheelbeek P; Silver MJ; Teh MR; Prentice AM
J Nutr; 2021 Jul; 151(7):1854-1878. PubMed ID: 33982105
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
